Treatment of Yunnan Baiyao plus Kangfuxin Solution Reduces Inflammatory Response and Prevents Patients with Nasopharyngeal Carcinoma against Radiation-Induced Oral Mucositis

<div>The screening process of eligible study subjects. Finally, 90 eligible patients with nasopharyngeal carcinoma meet predefined inclusion and exclusion criteria and were recruited into the present study.</div>

Journal of Nanomaterials

fig1

Figure 1

Figure 1: Treatment of Yunnan Baiyao plus Kangfuxin Solution Reduces Inflammatory Response and Prevents Patients with Nasopharyngeal Carcinoma against Radiation-Induced Oral Mucositis 

Figure 1 | Treatment of Yunnan Baiyao plus Kangfuxin Solution Reduces Inflammatory Response and Prevents Patients with Nasopharyngeal Carcinoma against Radiation-Induced Oral Mucositis 